spacer
home > epc > media info
MEDIA INFORMATION

Click here to view the EPC media pack

EPC offers an industry-leading platform, which includes:
  • An international readership of pharma and biotech decision makers, plus full-service and speciality CROs, in print
    and online
  • Strong, opinion-led editorial comment and analysis
  • Affiliation with international trade events and conferences
  • An impressive record of long-term advertising partnerships
    and a loyal affiliate network
  • Multimedia presence to reach a global audience
Each edition of EPC runs a number of expert, discussion-based features on the latest contract research and outsourcing moves.
Topics regularly covered include:
  • CRO market analysis
  • Biopharmaceutical development
  • Non-clinical pharmacology/toxicology
  • Laboratory services (bioanalytical labs, central labs)
  • Biosimilars development
  • Biomarkers and assay development
  • Data management
  • Biostatistics
  • Pharmacovigilance
  • Chemistry, manufacturing, controls
  • Strategic and regulatory planning
  • Pricing and market access
  • Contract planning
  • Outsourcing models (eg full service, functional service provider)
  • Supplier selection
  • Managing supplier relationships
  • Procurement practices
  • Technical innovation
  • Business process management
  • CRO performance metrics
spacer



Published quarterly in
February, May,
August, and November
 
Industry Events

CPhI & P-MEC India

26-28 November 2019, India Expo Centre, Greater Noida, Delhi NCR, India

As the pharma industry looks increasingly towards India forhigh quality, low   cost pharma solutions, CPhI & P-MEC Indiais the ideal event for companies wanting to pick up on the latest trends and innovations the market has to offer. At CPhI & P-MEC India, you will meet the movers and shakers from India’s pharma machinery, technology and ingredients industries, giving you a competitive advantage that will help grow your business.
More info >>

 
News and Press Releases

Drive for generics sees Korea increasingly attractive to international pharma

Amsterdam, 31st July 2019: Already home to more than 40 pharmaceutical multinationals, Korea is on course to become a global biotech and pharmaceutical hub by 2025, driven by the surge of international partnerships, biosimilars, an expansion in the export of finished formulations and a robust generics market.
More info >>

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement